Amaryllidaceae Alkaloid Cherylline Inhibits the Replication of Dengue and Zika Viruses
Open Access
- 17 August 2021
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 65 (9), e0039821
- https://doi.org/10.1128/aac.00398-21
Abstract
Dengue fever, caused by dengue virus (DENV), is the most prevalent arthropod-borne viral disease and is endemic in many tropical and subtropical parts of the world, with an increasing incidence in temperate regions. The closely related flavivirus Zika virus (ZIKV) can be transmitted vertically in utero and causes congenital Zika syndrome and other birth defects. In adults, ZIKV is associated with Guillain-Barre syndrome. There are no approved antiviral therapies against either virus. Effective antiviral compounds are urgently needed. Amaryllidaceae alkaloids (AAs) are a specific class of nitrogen-containing compounds produced by plants of the Amaryllidaceae family with numerous biological activities. Recently, the AA lycorine was shown to present strong antiflaviviral properties. Previously, we demonstrated that Crinum jagus contained lycorine and several alkaloids of the cherylline, crinine, and galanthamine types with unknown antiviral potential. In this study, we explored their biological activities. We show that C. jagus crude alkaloid extract inhibited DENV infection. Among the purified AAs, cherylline efficiently inhibited both DENV (50% effective concentration [EC50], 8.8 mu M) and ZIKV replication (EC50, 20.3 mu M) but had no effect on HIV-1 infection. Time-of-drug-addition and -removal experiments identified a postentry step as the one targeted by cherylline. Consistently, using subgenomic replicons and replication-defective genomes, we demonstrate that cherylline specifically hinders the viral RNA synthesis step but not viral translation. In conclusion, AAs are an underestimated source of antiflavivirus compounds, including the effective inhibitor cherylline, which could be optimized for new therapeutic approaches.Funding Information
- Canada Research Chairs (950-232164)
This publication has 84 references indexed in Scilit:
- Susceptibility and Response of Human Blood Monocyte Subsets to Primary Dengue Virus InfectionPLOS ONE, 2012
- Inhibition of Dengue Virus Entry and Multiplication into Monocytes Using RNA InterferencePLoS Neglected Tropical Diseases, 2011
- A Conserved Peptide in West Nile Virus NS4A Protein Contributes to Proteolytic Processing and Is Essential for ReplicationJournal of Virology, 2011
- Consequences of the Expanding Global Distribution of Aedes albopictus for Dengue Virus TransmissionPLoS Neglected Tropical Diseases, 2010
- A short synthesis of (±)-cherylline dimethyl etherBeilstein Journal of Organic Chemistry, 2009
- An adenosine nucleoside inhibitor of dengue virusProceedings of the National Academy of Sciences of the United States of America, 2009
- Flavivirus methyltransferase: A novel antiviral targetAntiviral Research, 2008
- Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue feverVirology, 2008
- Role of Dendritic Cells in Antibody-Dependent Enhancement of Dengue Virus InfectionJournal of Virology, 2008
- Regulated Cleavages at the West Nile Virus NS4A-2K-NS4B Junctions Play a Major Role in Rearranging Cytoplasmic Membranes and Golgi Trafficking of the NS4A ProteinJournal of Virology, 2006